<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00437710</url>
  </required_header>
  <id_info>
    <org_study_id>01/2007</org_study_id>
    <nct_id>NCT00437710</nct_id>
  </id_info>
  <brief_title>Safety and Efficacy of Bone Marrow Cell Transplantation in Humans Myocardial Infarction</brief_title>
  <acronym>CARDIAC</acronym>
  <official_title>Cardiac Study. Cellular Cardiomyoplasty of Infarcted Failed Myocardium by Autologous Intracoronary Mononuclear Bone Marrow Cell Transplantation in Humans</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Azienda Unità Sanitaria Locale di Piacenza</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Azienda Unità Sanitaria Locale di Piacenza</source>
  <brief_summary>
    <textblock>
      We will study in a prospective randomised fashion 50 patients who will be treated by
      intracoronary transplantation of autologous, mononuclear bone marrow cells (BMCs) in addition
      to standard therapy after MI or standard therapy.

      After standard therapy for acute MI, 10 patients were transplanted with autologous
      mononuclear BMCs via a balloon catheter placed into the infarct-related artery during balloon
      dilatation (percutaneous transluminal coronary angioplasty). Another 10 patients with acute
      MI were treated by standard therapy alone. After
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Experimental and clinical data suggest that bone marrow-derived cells may contribute to the
      healing of myocardial infarction (MI).
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>July 2005</start_date>
  <completion_date type="Anticipated">February 2007</completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Mortality</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>Mortality and Morbidity</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>Left ventricular function</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Left ventricular remodeling</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart rate variability</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Baroreflex sensitivity</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stress induced myocardial ischemia</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cell dose response</measure>
  </secondary_outcome>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Acute Myocardial Infarction</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>cell therapy, bone marrow derived stem cell</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Recent acute transmural anterior myocardial infarction, (in agreement with WHO)

          -  single left anterior descending coronary artery disease

          -  &lt;72 hour from the origin of symptoms

          -  successful primary angioplasty of the culprit lesion

        Exclusion Criteria:

          -  screening &gt;72 hours after infarction,

          -  cardiac shock, severe comorbidity, alcohol or drug dependency

          -  severe comorbidity (DM,renal or liver insufficiency)

          -  potential child bearing woman

          -  inability to provide informed consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Massimo Piepoli, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>G. da Saliceto Hospital, Regional Health Authority</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Massimo Piepoli, MD, PhD</last_name>
    <phone>+390 523 303217</phone>
    <email>m.piepoli@ausl.pc.it</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Daniele Vallisa, MD</last_name>
    <phone>+390 523 303737</phone>
    <email>d.vallisa@ausl.pc.it</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>G da Saliceto Hospital</name>
      <address>
        <city>Piacenza</city>
        <zip>29100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Massimo Piepoli, MD</last_name>
      <phone>+390 523 303217</phone>
      <email>m.piepoli@ausl.pc.it</email>
    </contact>
    <contact_backup>
      <last_name>Daniele Vallisa, MD</last_name>
      <phone>+390 523 303737</phone>
      <email>d.vallisa@ausl.pc.it</email>
    </contact_backup>
    <investigator>
      <last_name>Massimo Piepoli, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <link>
    <url>http://www.ausl.pc.it/</url>
    <description>Azienda USL Piacenza web site</description>
  </link>
  <verification_date>February 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 20, 2007</study_first_submitted>
  <study_first_submitted_qc>February 20, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 21, 2007</study_first_posted>
  <last_update_submitted>March 23, 2010</last_update_submitted>
  <last_update_submitted_qc>March 23, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 24, 2010</last_update_posted>
  <keyword>bone marrow, cell transplantation, stem cells, PTCA</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infarction</mesh_term>
    <mesh_term>Myocardial Infarction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

